(2024) BPC-157 as cytoprotection mediator with neurotransmitter-like activity Pharmaceuticals Sikiric et al
Public Health 13 , 11961201 (2020)
Features Benefits: How to use: Major Ingredients Water, Cyclopentasiloxane, Titanium Dioxide, Ethylhexyl Methoxycinnamate, Zinc Oxide, Ethylhexyl Salicylate, Neopentyl Glycol Diheptanoate, Phenyl Trimethicone, Butylene Glycol, Glycerin,Lauryl PEG-10 Tris(Trimethylsiloxy) Silylethyl Dimethicone, Niacinamide, Trimethylsiloxysilicate, Methyl Methacrylate Crosspolymer, Disteardimonium Hectorite, Iron Oxides (CI 77492), Pentylene Glycol, Polymethylsilsesquioxane, Magnesium Sulfate, PEG-10 Dimethicone, Aluminum Hydroxide, Polyglyceryl-4 Isostearate, Bis-ethylhexyloxyphenol Methoxyphenyl Triazine, Stearic Acid, Palmitic Acid, Dimethicone, Iron Oxides (Ci 77491), Methicone, Caprylyl Glycol, Glyceryl Caprylate, Stearyl Dimethicone, Iron Oxides(CI 77499), Ethylhexylglycerin, Dimethicone/Vinyl Dimethicone Crosspolymer, Glutathione, Fragrance, Triethoxycaprylylsilane, Adenosine, Myristic Acid, Olea Europaea (Olive) Fruit Oil, Oenothera Biennis (Evening Primrose) Oil, Carthamus Tinctorius (Safflower) Seed Oil, Rosa Canina Fruit Oil, Ectoin, Tocopherol, Alcohol, Eucalyptus Globulus Leaf Extract, Lauroyl Lysine, Pyrus Malus (Apple) Fruit Extract, 1,2 Hexanediol, Hydrogenated Lecithin, Bellis Perennis (Daisy) Flower Extract, Polyglyceryl-10 Stearate, Panthenol, Phenethyl Alcohol, Tocopheryl Acetate, Sodium Ascorbyl Phosphate, Pinus Palustris Leaf Extract, Oenothera Biennis (Evening Primrose) Flower Extract, Pueraria Lobata Root Extract, Ulmus Davidiana Root Extract, Sodium Chloride, Disodium Phosphate, Tripeptide-1, Thiamine HCL, Retinyl Palmitate, Pyridoxine, Biotin, Folic Acid, Acetyl Hexapeptide-8, Copper Tripeptide-1, Palmitoyl Pentapeptide-4, Palmitoyl Tripeptide-1, Potassium Phosphate, Potassium Chloride, Cyanocobalamin Ingredients subject to change at manufacturer's discretion
Die Formel wurde mit Vitamin C und Selen ergnzt
PD-L1 protects tumor-associated dendritic cells from ferroptosis during immunogenic chemotherapy
